CINECA IRIS Institutional Research Information System

RUBINI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.502
EU - Europa 1.073
AS - Asia 526
SA - Sud America 101
AF - Africa 17
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.413
IT - Italia 435
CN - Cina 272
ES - Italia 122
IE - Irlanda 119
DE - Germania 73
SG - Singapore 68
MX - Messico 57
SE - Svezia 52
JP - Giappone 44
FR - Francia 43
GB - Regno Unito 39
IN - India 37
BR - Brasile 34
RU - Federazione Russa 25
AR - Argentina 23
CA - Canada 23
VN - Vietnam 23
FI - Finlandia 20
PL - Polonia 19
RO - Romania 18
UA - Ucraina 17
CO - Colombia 15
NL - Olanda 15
HK - Hong Kong 14
KR - Corea 13
PT - Portogallo 12
TW - Taiwan 11
AT - Austria 10
IL - Israele 10
BE - Belgio 9
CH - Svizzera 8
EC - Ecuador 8
PE - Perù 8
PH - Filippine 8
TR - Turchia 8
CL - Cile 7
GR - Grecia 7
HU - Ungheria 7
EG - Egitto 6
IR - Iran 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
CR - Costa Rica 4
MA - Marocco 4
SI - Slovenia 4
VE - Venezuela 4
AU - Australia 3
DK - Danimarca 3
EU - Europa 3
HR - Croazia 3
PK - Pakistan 3
RS - Serbia 3
SA - Arabia Saudita 3
AM - Armenia 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
TN - Tunisia 2
BG - Bulgaria 1
BO - Bolivia 1
CU - Cuba 1
GT - Guatemala 1
IQ - Iraq 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.226
Salva come PNG Salva come JPEG
Città #
Chandler 232
Ann Arbor 155
Dublin 119
Fairfield 113
Turin 90
Ashburn 80
Torino 78
Sesto San Giovanni 75
Wilmington 63
Beijing 56
Woodbridge 49
Singapore 47
Medford 40
Cambridge 38
Nyköping 37
Redwood City 36
Houston 34
Seattle 30
Princeton 28
Hangzhou 21
Madrid 21
Milan 21
Dong Ket 20
New York 20
Paris 20
Mexico City 19
Rome 19
Shanghai 19
Tokyo 17
San Diego 16
Córdoba 15
Helsinki 15
Los Angeles 14
Dearborn 13
Chengdu 11
Hebei 11
Jacksonville 11
Wuhan 11
Berlin 10
Falls Church 10
Bologna 9
Guiyang 9
Hong Kong 9
Lisbon 9
Seoul 9
Barcelona 8
Cuenca 8
Guadalajara 8
Munich 8
Toronto 8
Athens 7
Brussels 7
Nanjing 7
Sevilla 7
Valencia 7
Vienna 7
Zhengzhou 7
Bengaluru 6
Changsha 6
Chicago 6
Lima 6
Mexico 6
Mumbai 6
Nuremberg 6
Seville 6
Shenyang 6
Wroclaw 6
Bari 5
Boston 5
Budapest 5
Chongqing 5
Delhi 5
Hyderabad 5
Mainz 5
Norwalk 5
Novosibirsk 5
Padova 5
Ravenna 5
Riverton 5
Rivoli 5
Rochester 5
Santander 5
Santiago 5
São Paulo 5
Terrassa 5
Washington 5
Acton 4
Amsterdam 4
Brasov 4
Bucaramanga 4
Bucharest 4
Buenos Aires 4
Chaoyang 4
Contagem 4
Frankfurt am Main 4
Freiburg im Breisgau 4
Guangzhou 4
Jinan 4
Kansas City 4
Kunming 4
Totale 2.079
Salva come PNG Salva come JPEG
Nome #
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab 328
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 255
Treatment of antiphospholipid syndrome 239
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome 213
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 197
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS 193
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score 164
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 146
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 101
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss 93
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 92
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 84
IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients 82
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 78
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 78
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology 78
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al 74
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome 64
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 63
Genetic factors in antiphospholipid syndrome: Preliminary experience with whole exome sequencing 63
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities 61
Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation 61
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies 56
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study 52
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy 50
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 47
"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach 42
Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients 36
Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine/ prothrombin antibodies 36
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol 35
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies 28
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head 28
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes 25
Serum Biomarkers of Renal Fibrosis: A Systematic Review 16
Daratumumab monotherapy for refractory lupus nephritis 15
New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing 13
2023 ACR/EULAR classification criteria in existing research cohorts: an international study 13
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 12
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) (vol 122, pg 1612, 2022) 4
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain 3
Totale 3.318
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020255 0 9 19 16 15 19 37 33 24 32 30 21
2020/2021463 25 28 71 76 28 21 19 37 43 34 25 56
2021/2022680 40 45 54 50 73 58 60 43 50 30 79 98
2022/2023920 91 87 43 72 85 182 63 68 73 32 74 50
2023/2024870 82 84 83 49 90 79 55 68 25 75 34 146
2024/202563 59 4 0 0 0 0 0 0 0 0 0 0
Totale 3.318